Protara Therapeutics, Inc. - TARA
About Gravity Analytica
Recent News
- 02.23.2026 - TARA-002 Demonstrates 68% Complete Response Rate at Six Months in BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
- 02.19.2026 - Protara Therapeutics to Participate in Upcoming Investor Conferences
- 02.02.2026 - Protara Therapeutics, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Recent Filings
- 02.17.2026 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
- 02.02.2026 - 424B7 Prospectus [Rule 424(b)(7)]
- 01.27.2026 - 4 Statement of changes in beneficial ownership of securities
- 01.27.2026 - 4 Statement of changes in beneficial ownership of securities
- 01.27.2026 - 4 Statement of changes in beneficial ownership of securities
- 01.27.2026 - 4 Statement of changes in beneficial ownership of securities
- 01.22.2026 - 4 Statement of changes in beneficial ownership of securities
- 01.22.2026 - 4 Statement of changes in beneficial ownership of securities
- 01.22.2026 - 4 Statement of changes in beneficial ownership of securities
- 01.22.2026 - 4 Statement of changes in beneficial ownership of securities